ATE406380T1 - Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen - Google Patents

Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen

Info

Publication number
ATE406380T1
ATE406380T1 AT01961444T AT01961444T ATE406380T1 AT E406380 T1 ATE406380 T1 AT E406380T1 AT 01961444 T AT01961444 T AT 01961444T AT 01961444 T AT01961444 T AT 01961444T AT E406380 T1 ATE406380 T1 AT E406380T1
Authority
AT
Austria
Prior art keywords
vaccines
gag
application
hiv peptides
preserved regions
Prior art date
Application number
AT01961444T
Other languages
English (en)
Inventor
Birger Soerensen
Original Assignee
Bionor Immuno As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionor Immuno As filed Critical Bionor Immuno As
Application granted granted Critical
Publication of ATE406380T1 publication Critical patent/ATE406380T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Extraction Or Liquid Replacement (AREA)
AT01961444T 2000-09-04 2001-09-03 Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen ATE406380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004413A NO314588B1 (no) 2000-09-04 2000-09-04 HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV

Publications (1)

Publication Number Publication Date
ATE406380T1 true ATE406380T1 (de) 2008-09-15

Family

ID=19911533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961444T ATE406380T1 (de) 2000-09-04 2001-09-03 Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen

Country Status (20)

Country Link
US (2) US7009037B2 (de)
EP (2) EP1322665B1 (de)
JP (2) JP2004508381A (de)
CN (2) CN1282656C (de)
AR (2) AR033998A1 (de)
AT (1) ATE406380T1 (de)
AU (3) AU2001282706B2 (de)
BR (1) BR0114036A (de)
CA (1) CA2421193A1 (de)
DE (1) DE60135564D1 (de)
EA (1) EA006308B1 (de)
ES (1) ES2312465T3 (de)
HK (1) HK1059940A1 (de)
HU (1) HUP0303134A3 (de)
MY (1) MY136081A (de)
NO (1) NO314588B1 (de)
NZ (2) NZ524556A (de)
SK (1) SK287917B6 (de)
WO (1) WO2002020554A2 (de)
ZA (1) ZA200301740B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0108210A (pt) 2000-02-04 2002-10-22 Univ Duke Vacina contra o vìrus da imunodeficiência humana
EP2045282B1 (de) * 2005-08-26 2011-03-23 Novo Nordisk A/S Verfahren zur Modifizierung von Polymeren
FI120376B (fi) * 2007-01-17 2009-09-30 Next Biomed Technologies Nbt O Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi
FI120349B (fi) 2007-03-07 2009-09-30 Next Biomed Technologies Nbt O Menetelmä fuusiopolypeptidin valmistamiseksi
AP2857A (en) 2008-09-09 2014-02-28 Celebrity Biogens Llc Bioactive composition for the treatment of the HIV/AIDS, method for manufacturing and using the same
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
FR2957933B1 (fr) * 2010-03-24 2012-04-27 Seppic Sa Vaccin vivant pour maladies aviaires
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP3338798A1 (de) * 2011-01-06 2018-06-27 Bionor Immuno AS Multimere peptide
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
WO2013182661A1 (en) 2012-06-06 2013-12-12 Bionor Immuno As Peptides derived from viral proteins for use as immunogens and dosage reactants
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
EP2976325B1 (de) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthese von peptidprodukten mit cyclischem imid
CA2907454C (en) 2013-03-21 2021-05-04 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2017007994A1 (en) 2015-07-08 2017-01-12 American Gene Technologies International Inc. Hiv pre-immunization and immunotherapy
CN111569090A (zh) 2016-01-15 2020-08-25 美国基因技术国际有限公司 用于活化γ-δ T细胞的方法和组合物
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
JP7153332B2 (ja) 2016-02-08 2022-10-14 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド Ｈｉｖワクチン接種および免疫療法
JP7017247B2 (ja) 2016-03-09 2022-02-08 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド がんを処置するための組み合わせベクターおよび方法
WO2017213697A1 (en) 2016-06-08 2017-12-14 American Gene Technologies International Inc. Non-integrating viral delivery system and methods related thereto
JP6971492B2 (ja) 2016-07-08 2021-11-24 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド Ｈｉｖ予備免疫化および免疫療法
JP7176756B2 (ja) 2016-07-21 2022-11-22 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド パーキンソン病を処置するためのウイルスベクター
EP3607072A4 (de) 2017-04-03 2021-01-06 American Gene Technologies International Inc. Zusammensetzungen und verfahren zur behandlung von phenylketonurie
US11352646B2 (en) 2018-11-05 2022-06-07 American Gene Technologies International Inc. Vector system for expressing regulatory RNA
RU2727673C1 (ru) * 2019-08-09 2020-07-22 Федеральное государственное унитарное предприятие «Государственный научно-исследовательский институт особо чистых биопрепаратов» Федерального медико-биологического агентства Антитела против белка р17 ВИЧ-1 субтипа А
GB2610556A (en) * 2021-09-02 2023-03-15 113 Botanicals Ltd Extraction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
SE468168B (sv) 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
EP0907740A1 (de) 1997-01-02 1999-04-14 Universidade Federal De Minas Gerais VERFAHREN ZUR EXPRESSION UND HERSTELLUNG VON REKOMBINANTEM HYBRIDPROTEIN (p24/p17) AUS DEM HUMANEN IMMUNDEFIZIENZ VIRUS (HIV-1)
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
US5972339A (en) 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
EP1078092B1 (de) 1998-05-13 2011-08-03 Epimmune Inc. Expressionsvektoren zur stimulierung einer immunantwort und verfahren zu deren verwendung
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV

Also Published As

Publication number Publication date
CN101104636A (zh) 2008-01-16
AU2007202739A1 (en) 2007-07-05
EP1878742A2 (de) 2008-01-16
US20070237783A1 (en) 2007-10-11
NZ524556A (en) 2005-01-28
AU8270601A (en) 2002-03-22
HUP0303134A3 (en) 2012-09-28
HUP0303134A2 (hu) 2005-03-29
JP2004508381A (ja) 2004-03-18
JP2011219481A (ja) 2011-11-04
CN1460111A (zh) 2003-12-03
BR0114036A (pt) 2003-07-22
MY136081A (en) 2008-08-29
EP1322665B1 (de) 2008-08-27
EA006308B1 (ru) 2005-10-27
NO20004413D0 (no) 2000-09-04
EP1878742A3 (de) 2008-04-30
ZA200301740B (en) 2004-06-21
SK4022003A3 (en) 2003-09-11
CA2421193A1 (en) 2002-03-14
NO314588B1 (no) 2003-04-14
SK287917B6 (sk) 2012-03-02
EP1322665A2 (de) 2003-07-02
WO2002020554A3 (en) 2002-06-13
WO2002020554A2 (en) 2002-03-14
AR033998A1 (es) 2004-01-21
EA200300336A1 (ru) 2003-08-28
AR071262A2 (es) 2010-06-09
AU2001282706B2 (en) 2007-03-22
NO20004413L (no) 2002-03-05
US7612168B2 (en) 2009-11-03
CN1282656C (zh) 2006-11-01
DE60135564D1 (de) 2008-10-09
NZ535148A (en) 2007-06-29
US7009037B2 (en) 2006-03-07
US20040115615A1 (en) 2004-06-17
ES2312465T3 (es) 2009-03-01
HK1059940A1 (en) 2004-07-23
AU2007202739B2 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
ATE406380T1 (de) Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
NL1015859A1 (nl) Farmaceutische preparaten.
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
BR0210005B1 (pt) Polímero, processo para o preparo do mesmo e estrutura absorvente.
ZA200207644B (en) Viral vectors for use in monitoring HIV drug resistance.
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
DE60236099D1 (de) Druckverfahren, druckerzeugnisse und drucksteuerung
DE60131432D1 (de) Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
IT1321052B1 (it) Perfezionamenti in, o relativi a, attenuatori e dispositiviamplificatori.
DE60113556D1 (de) Applikator, z.b. für rasierpräparate und dergleichen
DE50213606D1 (de) Zylinder im Falzapparat
JP2002275230A5 (de)
IT1318578B1 (it) Articolatore, particolarmente per le applicazioni in odontoiatria eodontotecnica.
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
DE29722970U1 (de) Verpackung, in der Scheren o.ä. betätigt werden können
ITRM20010670A1 (it) Piante ricombinanti e costrutti di dna.
RU2001100069A (ru) Антгельминтное средство
RU2001127052A (ru) Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов
ES1045336Y (es) Maquina cortadora de raiz y talle de ajos.
Fox Ancient Two-Legged Lizard Intrigues Scientists
IL157753A0 (en) Natural antibody active against hiv virus
IT251674Y1 (it) "perfezionamento nei dispositivi denominati idrobar,idrotuba,idrosfera e simili".
ג'וני גל Social Services in the Workplace

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties